NDC 75834-206

NATEGLINIDE

Nateglinide

NATEGLINIDE is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is Nateglinide.

Product ID75834-206_4b5b12e1-59db-4ec2-a2be-9b60abc79ebf
NDC75834-206
Product TypeHuman Prescription Drug
Proprietary NameNATEGLINIDE
Generic NameNateglinide
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2019-09-25
Marketing CategoryANDA / ANDA
Application NumberANDA206432
Labeler NameNivagen Pharmaceuticals, Inc.
Substance NameNATEGLINIDE
Active Ingredient Strength120 mg/1
Pharm ClassesGlinide [EPC],Potassium Channel Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 75834-206-01

100 TABLET, COATED in 1 BOTTLE (75834-206-01)
Marketing Start Date2019-09-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 75834-206-01 [75834020601]

NATEGLINIDE TABLET, COATED
Marketing CategoryANDA
Application NumberANDA206432
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-09-25

Drug Details

Active Ingredients

IngredientStrength
NATEGLINIDE120 mg/1

OpenFDA Data

SPL SET ID:21b211b5-cc92-490f-9903-42fff6a946cd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 311919
  • 314142
  • UPC Code
  • 0375834206011
  • 0375834205014
  • Pharmacological Class

    • Glinide [EPC]
    • Potassium Channel Antagonists [MoA]
    • Glinide [EPC]
    • Potassium Channel Antagonists [MoA]

    NDC Crossover Matching brand name "NATEGLINIDE" or generic name "Nateglinide"

    NDCBrand NameGeneric Name
    0591-3354NateglinideNateglinide
    0591-3355NateglinideNateglinide
    0615-7585NateglinideNateglinide
    0615-7586NateglinideNateglinide
    16571-758NATEGLINIDENATEGLINIDE
    16571-759NATEGLINIDENATEGLINIDE
    42291-636NateglinideNateglinide
    42291-637NateglinideNateglinide
    49884-984NateglinideNateglinide
    49884-985NateglinideNateglinide
    51407-656Nateglinidenateglinide
    51407-657Nateglinidenateglinide
    52536-063NateglinideNateglinide
    52536-067NateglinideNateglinide
    55111-328NateglinideNateglinide
    55111-329NateglinideNateglinide
    60429-434NateglinideNateglinide
    60429-435NateglinideNateglinide
    60687-673Nateglinidenateglinide
    60687-684Nateglinidenateglinide
    64380-167Nateglinidenateglinide
    64380-168Nateglinidenateglinide
    68084-458NateglinideNateglinide
    68084-459NateglinideNateglinide
    68382-721NateglinideNateglinide
    68382-722NateglinideNateglinide
    70771-1016NateglinideNateglinide
    70771-1015NateglinideNateglinide
    71209-030NateglinideNateglinide
    71209-031NateglinideNateglinide
    75834-205NATEGLINIDENATEGLINIDE
    75834-206NATEGLINIDENATEGLINIDE
    0078-0351Starlixnateglinide
    0078-0352Starlixnateglinide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.